ARCHIVES

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

This article is from The Cancer Letter archive.

Vol. 20 No. 24 | June 17, 1994

Download PDF Visit The Full Archive

Related Articles

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

NIEHS, Five Grantees Form Toxicogenomics Group.

November 16, 2001

Nexavar Approved For Patients With Inoperable Liver Cancer

November 30, 2007

NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War

October 3, 1986